256 Newsroom — Uganda's Digital News Infrastructure
Business

Three deaths in CAR-T trials prompt halt by Novartis; Bristol Myers programs also paused - Endpoints News

Published by Endpoints.news By Nicole DeFeudis · 1 September 2026 at 03:01
Share
Three deaths in CAR-T trials prompt halt by Novartis; Bristol Myers programs also paused - Endpoints News
Image · Endpoints.news

What the report says

Novartis halts CAR-T trials after three patient deaths from an immune overreaction; Bristol Myers pauses zola-cel enrollment.

Read the full report at Endpoints.news →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

More stories by this journalist

Other publications from this journalist — open any story without leaving the article page.

No other published stories from this publisher yet.

Related reporting

Uganda and Nigeria Commit to Action-Driven Deals at Kampala ForumSoftPower News Why Dying Without a Will Can Tear Families ApartDokolo Post Uganda, Malaysian Coffee Firm Discuss Boosting Coffee Exports to ASEANSoftPower News 256 Newsroom Former trade PS Geraldine Ssali and co-accused take fresh plea to amended charges in Shs3.8bn war compensation case - PML DailyPML Daily Report highlights role of generic drugmakers in expanding medicine access in AfricaThe Observer BRICS 2026: New Delhi prepares for a summit that could reshape the Global SouthNile Post